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Purpose
Clonidine and brimonidine, two α2 agonists, have been
shown to reduce intraocular pressure in glaucoma
patients. Little is, however, known about the exact role of
alpha receptors in the control of ocular blood flow in the
posterior pole of the eye. Hence, we set out to investigate
the effects of topical clonidine vs. topical brimonidine on
choroidal blood flow and intraocular pressure during iso-
metric exercise.
Methods
We performed a randomized double-masked, controlled
two-way cross-over study. Twelve healthy male non-
smoking volunteers, aged between 19 and 35 years were
included in the study. Two drops of clonidine or brimoni-
dine were administered in the subjects' study eyes. Con-
tinuous measurement using the compact laser Doppler
Flowmeter was done during a 6 minutes squatting period,
to assess choroidal blood flow regulation during an
increase in ocular perfusion pressure.
Results
IOP decreased significantly after administration of the α2
agonists (p < 0.001 vs. each baseline, p = 0.8 between
groups). Choroidal blood flow was significantly reduced
by both drugs at baseline (p < 0.01 each) as well as during
isometric exercise (p < 0.01 each). Vascular resistance
increased at baseline and during squatting after adminis-
tration of the α2 agonists (p < 0.01) in both groups to a
comparable degree (p = 0.56).
Conclusion
Alpha-2 agonists may induce changes in choroidal blood
flow even after single topical administration. Long-term
studies are required to study potential effects of brimoni-
dine and clonidine in the clinical setting.
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